Trial Profile
Treatment of Refractory Nausea
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2024
Price :
$35
*
At a glance
- Drugs Netupitant/palonosetron (Primary) ; Dexamethasone; Olanzapine; Prochlorperazine
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 16 Jan 2024 Planned End Date changed from 30 Jun 2025 to 30 Jun 2024.
- 16 Jan 2024 Planned primary completion date changed from 30 Jun 2025 to 1 Apr 2024.
- 07 Feb 2023 Planned number of patients changed from 1200 to 1600.